Leo Wealth LLC purchased a new position in Exelon Corporation (NASDAQ:EXC – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 25,773 shares of the company’s stock, valued at approximately $1,041,000.
A number of other large investors also recently modified their holdings of EXC. BlackRock Inc. acquired a new stake in Exelon in the second quarter worth about $5,583,709,000. GQG Partners LLC bought a new position in Exelon in the 2nd quarter valued at about $922,917,000. Legal & General Group Plc acquired a new position in Exelon during the 2nd quarter valued at about $602,760,000. Bank of New York Mellon Corp acquired a new position in Exelon during the 2nd quarter valued at about $580,842,000. Finally, Deutsche Bank AG bought a new stake in shares of Exelon during the 2nd quarter worth about $567,510,000. 80.92% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on EXC. BMO Capital Markets reduced their price target on shares of Exelon from $47.00 to $45.00 and set a “market perform” rating for the company in a research note on Thursday, October 22nd. Barclays lowered their price objective on shares of Exelon from $49.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. HSBC initiated coverage on Exelon in a report on Thursday, October 22nd. They set a “hold” rating and a $44.00 target price on the stock. Jefferies Financial Group cut their target price on Exelon from $50.00 to $49.00 and set a “hold” rating for the company in a research report on Wednesday, July 29th. Finally, The Goldman Sachs Group decreased their price target on Exelon from $45.00 to $44.00 in a research note on Thursday, October 15th. Six research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $48.58.
Get Our Latest Stock Analysis on Exelon
Exelon Price Performance
NASDAQ:EXC opened at $44.54 on Tuesday. The business’s 50-day moving average price is $42.85 and its 200 day moving average price is $45.53. The firm has a market cap of $45.98 billion, a P/E ratio of 16.32, a PEG ratio of 2.43 and a beta of 0.30. Exelon Corporation has a 52-week low of $39.73 and a 52-week high of $50.65. The company has a quick ratio of 0.99, a current ratio of 1.09 and a debt-to-equity ratio of 1.71.
Exelon (NASDAQ:EXC – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.01). Exelon had a return on equity of 9.81% and a net margin of 10.99%. The business had revenue of $5.97 billion during the quarter, compared to the consensus estimate of $5.44 billion. During the same quarter last year, the firm posted $0.39 earnings per share. Exelon’s revenue was up 10.0% compared to the same quarter last year. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. As a group, sell-side analysts predict that Exelon Corporation will post 2.86 earnings per share for the current fiscal year.
About Exelon
Exelon Corporation (NASDAQ:EXC) is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.
Exelon’s utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.
See Also
- Five stocks we like better than Exelon
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.
